Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568202280> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2568202280 endingPage "61" @default.
- W2568202280 startingPage "57" @default.
- W2568202280 abstract "Purpose To evaluate the clinical outcome of patients with venous malformation (VM) involving the eyelid treated with bleomycin sclerotherapy. Methods A retrospective review was performed of 18 consecutive patients with VM involving the eyelid who underwent bleomycin sclerotherapy. Patients’ clinical presentation, details of sclerotherapy, and post-sclerotherapy resolution of the lesion as well as any procedure-related complications were evaluated. Results Twelve women and six men of mean age 34.3±20.4 years underwent sclerotherapy with bleomycin. Chief complaints were cosmetic disfigurations with or without hemifacial deformity (n=2), pain in engorgement area (n=2), pain and swelling from venous thrombosis (n=2), swelling or engorgement obstructing their eyesight (n=2), or eyelid dysfunction (n=1). The lesions were only in the eyelid in three patients; otherwise they were extended out of the eyelid either superiorly (n=3), laterally (n=8), inferiorly (n=8), and/or posteriorly to the orbit (n=8) to various extents. Conjunctival involvement was present in 13 patients. 14 patients had received prior treatments including surgery, laser therapy, or non-bleomycin sclerotherapy. With an average three sessions of bleomycin sclerotherapy (average total dose 34.5 mg), more than 80% shrinkage was observed in seven patients (38.9%), 50–80% shrinkage in eight patients (44.4%), and 30–50% shrinkage in two patients (11.1%). One patient had recurrence, which was successfully treated again with bleomycin. No procedure-related complications were noted. Conclusions The use of bleomycin appears to be a simple, safe, and effective treatment for venous malformations involving the eyelid, avoiding more elaborate and challenging surgical or laser interventions, and is even effective in full thickness lesions." @default.
- W2568202280 created "2017-01-13" @default.
- W2568202280 creator A5051509199 @default.
- W2568202280 creator A5057384442 @default.
- W2568202280 creator A5068524220 @default.
- W2568202280 creator A5084510286 @default.
- W2568202280 date "2018-04-19" @default.
- W2568202280 modified "2023-10-16" @default.
- W2568202280 title "Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy" @default.
- W2568202280 cites W1706030773 @default.
- W2568202280 cites W1706136667 @default.
- W2568202280 cites W1937582489 @default.
- W2568202280 cites W1972646275 @default.
- W2568202280 cites W1974073698 @default.
- W2568202280 cites W1978456800 @default.
- W2568202280 cites W1985333268 @default.
- W2568202280 cites W1993726573 @default.
- W2568202280 cites W1995232821 @default.
- W2568202280 cites W1995255092 @default.
- W2568202280 cites W2028807203 @default.
- W2568202280 cites W2036399995 @default.
- W2568202280 cites W2051118728 @default.
- W2568202280 cites W2072603916 @default.
- W2568202280 cites W2079335958 @default.
- W2568202280 cites W2079778275 @default.
- W2568202280 cites W2087307665 @default.
- W2568202280 cites W2088725879 @default.
- W2568202280 cites W2124772324 @default.
- W2568202280 cites W2136722679 @default.
- W2568202280 cites W2144136228 @default.
- W2568202280 cites W2171086580 @default.
- W2568202280 cites W2272536569 @default.
- W2568202280 cites W2340474667 @default.
- W2568202280 cites W4242170407 @default.
- W2568202280 doi "https://doi.org/10.1136/neurintsurg-2018-013813" @default.
- W2568202280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29674482" @default.
- W2568202280 hasPublicationYear "2018" @default.
- W2568202280 type Work @default.
- W2568202280 sameAs 2568202280 @default.
- W2568202280 citedByCount "11" @default.
- W2568202280 countsByYear W25682022802018 @default.
- W2568202280 countsByYear W25682022802020 @default.
- W2568202280 countsByYear W25682022802021 @default.
- W2568202280 countsByYear W25682022802022 @default.
- W2568202280 crossrefType "journal-article" @default.
- W2568202280 hasAuthorship W2568202280A5051509199 @default.
- W2568202280 hasAuthorship W2568202280A5057384442 @default.
- W2568202280 hasAuthorship W2568202280A5068524220 @default.
- W2568202280 hasAuthorship W2568202280A5084510286 @default.
- W2568202280 hasConcept C141071460 @default.
- W2568202280 hasConcept C2776232574 @default.
- W2568202280 hasConcept C2776321279 @default.
- W2568202280 hasConcept C2776694085 @default.
- W2568202280 hasConcept C2778230777 @default.
- W2568202280 hasConcept C2781302119 @default.
- W2568202280 hasConcept C71924100 @default.
- W2568202280 hasConceptScore W2568202280C141071460 @default.
- W2568202280 hasConceptScore W2568202280C2776232574 @default.
- W2568202280 hasConceptScore W2568202280C2776321279 @default.
- W2568202280 hasConceptScore W2568202280C2776694085 @default.
- W2568202280 hasConceptScore W2568202280C2778230777 @default.
- W2568202280 hasConceptScore W2568202280C2781302119 @default.
- W2568202280 hasConceptScore W2568202280C71924100 @default.
- W2568202280 hasIssue "1" @default.
- W2568202280 hasLocation W25682022801 @default.
- W2568202280 hasLocation W25682022802 @default.
- W2568202280 hasOpenAccess W2568202280 @default.
- W2568202280 hasPrimaryLocation W25682022801 @default.
- W2568202280 hasRelatedWork W2013382873 @default.
- W2568202280 hasRelatedWork W2069510170 @default.
- W2568202280 hasRelatedWork W2154362091 @default.
- W2568202280 hasRelatedWork W2371446911 @default.
- W2568202280 hasRelatedWork W2376445419 @default.
- W2568202280 hasRelatedWork W2418055817 @default.
- W2568202280 hasRelatedWork W2568202280 @default.
- W2568202280 hasRelatedWork W2911955798 @default.
- W2568202280 hasRelatedWork W2946142370 @default.
- W2568202280 hasRelatedWork W3042845914 @default.
- W2568202280 hasVolume "11" @default.
- W2568202280 isParatext "false" @default.
- W2568202280 isRetracted "false" @default.
- W2568202280 magId "2568202280" @default.
- W2568202280 workType "article" @default.